Velos Investigational Drug System Doubles Install Base in One Year
FREMONT, CALIFORNIA – July 26, 2018
Velos, Inc., a clinical research management software vendor, is pleased to announce impressive growth of the company’s Investigational Drug Management System through continued product innovation. In one year alone, Velos Investigational Drug System (Velos IDS) has doubled its customer base. The product is now being used to manage drug accountability logs for over 10,000 studies at healthcare organizations across the country.
The recent customer base growth and adoption of the Velos Investigational Drug System are testaments to the numerous benefits and investment returns of the product. With a cloud-based offering, Velos IDS enables hassle free installation and quick setup. It comes prepackaged with capabilities and time-saving tools that make drug accountability services more efficient. With a few clicks, customers can track expiration and patient-specific meds, print barcoded labels and prescriptions, set par levels, conduct audits, manage inventories across multiple pharmacies and storage locations, and effortlessly generate reports for compliance and monitoring purposes. The solution integrates with many third-party systems that create additional efficiencies and process automation.
“Paper logs and binders are becoming a thing of the past,” explains Velos IDS Product Director Nick Bobrinskoy. “With each deployment, we continue to receive elated feedback on the ease of use and intuitive design of Velos IDS and its ability to integrate with our customers’ other pharmacy, medical record, and research systems. The efficiency gains are visible all over the pharmacy.”
“In addition to new customer wins, we’ve experienced significant growth in the Velos IDS adoption among existing Velos eResearch customers,” says CEO John McIlwain. “Velos provides the most comprehensive, integrated product line for managing clinical research from protocol design and review to subject recruitment to study fulfillment and follow-up. We are pleased to see more and more customers harness the value of this comprehensive approach with Velos IDS being a great example.”
Velos is the trusted clinical trial management resource for investigators, sponsors, and academic leaders throughout the world. Velos integrates the clinical, administrative and financial information needs of research management, with an emphasis on flexibility and workflow and empowering clinical innovation. Founded in 1996, Velos, Inc. is privately held with headquarters in Fremont, California. For more information, visit www.velos.com